Genomic Screening With Gene Panel Sequencing Feasible for Use in Targeted Drug Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Implications of Routine Genomic Mutation Sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in Metastatic Breast Cancer
Breast Cancer Res Treat 2016 Nov 01;160(1)69-77, JM Cejalvo, JA Pérez-Fidalgo, G Ribas, O Burgués, C Mongort, E Alonso, M Ibarrola-Villava, B Bermejo, MT Martínez, A Cervantes, A LluchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.